Cargando…
Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880707/ https://www.ncbi.nlm.nih.gov/pubmed/35221736 http://dx.doi.org/10.2147/RMHP.S345059 |
_version_ | 1784659286107881472 |
---|---|
author | Lin, Mengyue Heizhati, Mulalibieke Gan, Lin Yao, Ling Yang, Wenbo Li, Mei Hong, Jing Wu, Zihao Wang, Hui Li, Nanfang |
author_facet | Lin, Mengyue Heizhati, Mulalibieke Gan, Lin Yao, Ling Yang, Wenbo Li, Mei Hong, Jing Wu, Zihao Wang, Hui Li, Nanfang |
author_sort | Lin, Mengyue |
collection | PubMed |
description | PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with GMD were consecutively included. Baseline data were extracted from medical electronic system, and follow-up data were obtained using annual health check-ups or hospital readmission. KD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m(2). Subjects were randomly divided into training and validation sets with a ratio of 7 to 3. Least absolute shrinkage and selection operator method was used to identify potential predictors. Cox proportional hazard model was applied to build a nomogram for predicting KD risk. The discriminative ability, calibration and usefulness of the model were evaluated. The prediction model was verified by internal validation. RESULTS: During the follow-up of 5351 person-years with a median follow-up of 32 (range: 3–91) months, 130 patients developed KD. Age, sex, ethnicity, hemoglobin A1c, uric acid, and baseline eGFR were identified as significant predictors for incident KD and used for establishing nomogram. The prediction model displayed good discrimination with C-index of 0.770 (95% CI: 0.712–0.828) and 0.763 (95% CI: 0.704–0.823) in training and validation sets, respectively. Calibration curve indicated good agreement between the predicted and actual probabilities. The decision curve analysis demonstrated that the model was clinically useful. CONCLUSION: The prediction nomogram, including six common easy-to-obtain factors, shows good performance for predicting 5-year risk of KD in hypertensives with GMD. This quantitative tool could help clinicians, and even primary care providers, recognize potential KD patients early and make strategy for prevention and management. |
format | Online Article Text |
id | pubmed-8880707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-88807072022-02-26 Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder Lin, Mengyue Heizhati, Mulalibieke Gan, Lin Yao, Ling Yang, Wenbo Li, Mei Hong, Jing Wu, Zihao Wang, Hui Li, Nanfang Risk Manag Healthc Policy Original Research PURPOSE: Patients with hypertension and glucose metabolism disorder (GMD) are at high risk of developing kidney dysfunction (KD). Therefore, we aimed to develop a nomogram for predicting individuals’ 5-year risk of KD in hypertensives with GMD. PATIENTS AND METHODS: In total, 1961 hypertensives with GMD were consecutively included. Baseline data were extracted from medical electronic system, and follow-up data were obtained using annual health check-ups or hospital readmission. KD was defined as estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m(2). Subjects were randomly divided into training and validation sets with a ratio of 7 to 3. Least absolute shrinkage and selection operator method was used to identify potential predictors. Cox proportional hazard model was applied to build a nomogram for predicting KD risk. The discriminative ability, calibration and usefulness of the model were evaluated. The prediction model was verified by internal validation. RESULTS: During the follow-up of 5351 person-years with a median follow-up of 32 (range: 3–91) months, 130 patients developed KD. Age, sex, ethnicity, hemoglobin A1c, uric acid, and baseline eGFR were identified as significant predictors for incident KD and used for establishing nomogram. The prediction model displayed good discrimination with C-index of 0.770 (95% CI: 0.712–0.828) and 0.763 (95% CI: 0.704–0.823) in training and validation sets, respectively. Calibration curve indicated good agreement between the predicted and actual probabilities. The decision curve analysis demonstrated that the model was clinically useful. CONCLUSION: The prediction nomogram, including six common easy-to-obtain factors, shows good performance for predicting 5-year risk of KD in hypertensives with GMD. This quantitative tool could help clinicians, and even primary care providers, recognize potential KD patients early and make strategy for prevention and management. Dove 2022-02-21 /pmc/articles/PMC8880707/ /pubmed/35221736 http://dx.doi.org/10.2147/RMHP.S345059 Text en © 2022 Lin et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Lin, Mengyue Heizhati, Mulalibieke Gan, Lin Yao, Ling Yang, Wenbo Li, Mei Hong, Jing Wu, Zihao Wang, Hui Li, Nanfang Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title | Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title_full | Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title_fullStr | Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title_full_unstemmed | Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title_short | Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder |
title_sort | development and validation of a prediction model for 5-year risk of kidney dysfunction in patients with hypertension and glucose metabolism disorder |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880707/ https://www.ncbi.nlm.nih.gov/pubmed/35221736 http://dx.doi.org/10.2147/RMHP.S345059 |
work_keys_str_mv | AT linmengyue developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT heizhatimulalibieke developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT ganlin developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT yaoling developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT yangwenbo developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT limei developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT hongjing developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT wuzihao developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT wanghui developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder AT linanfang developmentandvalidationofapredictionmodelfor5yearriskofkidneydysfunctioninpatientswithhypertensionandglucosemetabolismdisorder |